Publicaciones en colaboración con investigadores/as de Universidad de Castilla-La Mancha (42)

2024

  1. Are perceived barriers to physical activity related to depression, anxiety and stress among adolescents? The EHDLA study

    BMJ Open Sport and Exercise Medicine, Vol. 10, Núm. 3

  2. Resilience to structural and molecular changes in excitatory synapses in the hippocampus contributes to cognitive function recovery in Tg2576 mice

    Neural Regeneration Research, Vol. 19, Núm. 9, pp. 2068-2074

2023

  1. A Cluster Randomized Controlled Trial of the Archena Infancia Saludable Project on 24-h Movement Behaviors and Adherence to the Mediterranean Diet among Schoolchildren: A Pilot Study Protocol

    Children, Vol. 10, Núm. 4

  2. Effectiveness and safety of fluocinolone acetonide intravitreal implant in diabetic macular edema patients considered insufficiently responsive to available therapies (REACT): a prospective, non-randomized, and multicenter study

    International Ophthalmology, Vol. 43, Núm. 12, pp. 4639-4649

  3. Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver

    Molecular Genetics and Metabolism Reports, Vol. 35

  4. Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations

    British Journal of Haematology, Vol. 201, Núm. 5, pp. 971-981

  5. Overall proportion of orthorexia nervosa symptoms: A systematic review and meta-analysis including 30 476 individuals from 18 countries

    Journal of global health, Vol. 13, pp. 04087

2022

  1. ACE-Vitamin Index and Risk of Glaucoma: The SUN Project

    Nutrients, Vol. 14, Núm. 23

  2. How the COVID-19 pandemic has affected the training of Endocrinology and Nutrition Residents. Results of a survey by the Spanish Society of Endocrinology and Nutrition

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 3, pp. 219-226

2021

  1. Amyloid-driven tau accumulation on mitochondria potentially leads to cognitive deterioration in alzheimer’s disease

    International Journal of Molecular Sciences, Vol. 22, Núm. 21

  2. Cerebral Insulin Bolus Revokes the Changes in Hepatic Lipid Metabolism Induced by Chronic Central Leptin Infusion

    Cells, Vol. 10, Núm. 3

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study

    PharmacoEconomics - Open, Vol. 4, Núm. 4, pp. 615-624

  2. Genetic and environmental factors related to the development of myopic maculopathy in Spanish patients

    PloS one, Vol. 15, Núm. 7, pp. e0236071

  3. PLA2G4E, a candidate gene for resilience in Alzheimer´s disease and a new target for dementia treatment

    Progress in Neurobiology, Vol. 191

2019

  1. Myopic maculopathy: Current status and proposal for a new classification and grading system (ATN)

    Progress in Retinal and Eye Research, Vol. 69, pp. 80-115

2018

  1. Clinical decision-making when treating diabetic macular edema patients with dexamethasone intravitreal implants

    Ophthalmologica, Vol. 240, Núm. 2, pp. 61-72

  2. PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy

    Journal of Controlled Release, Vol. 276, pp. 125-139

  3. The increase in fiber size in male rat gastrocnemius after chronic central leptin infusion is related to activation of insulin signaling

    Molecular and Cellular Endocrinology, Vol. 470, pp. 48-59

2017

  1. 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of malignancy in patients with paraneoplastic neurological syndrome: a systematic review and meta-analysis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 44, Núm. 9, pp. 1575-1587